FORE CAPITAL LLC
Q2 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001714672
· Institutional investment manager
$338.4M Reported Value Total
Reported value
$338.4M
Quarter over quarter
-3.6%
Holdings
35
Top-10 concentration
73.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Ushane Sharma
Authorized Signatory
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 10, 2026 |
| Form | 13F-HR |
| Reported value | $338.4M |
| Positions | 35 |
| Change in reported value | +109.5% |
| New positions | 29 |
| Exited positions | 6 |
| Position turnover | 85.4% |
| Top-10 concentration | 73.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 10, 2026
|
35 | $338.4M |
|
Q1 2026 13F
Filed May 8, 2026
|
16 | $161.6M |
|
Q4 2025 13F
Filed Feb 11, 2026
|
29 | $306.0M |
|
Q3 2025 13F
Filed Nov 13, 2025
|
30 | $348.5M |
|
Q2 2025 13F
Filed Aug 11, 2025
|
22 | $280.7M |
|
Q1 2025 13F
Filed May 13, 2025
|
35 | $169.2M |
|
Q4 2024 13F
Filed Feb 10, 2025
|
22 | $262.0M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
22 | $238.7M |
|
Q2 2024 13F
Filed Aug 7, 2024
|
30 | $157.4M |
|
Q1 2024 13F
Filed May 7, 2024
|
22 | $162.8M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
15 | $203.6M |
|
Q3 2023 13F
Filed Nov 6, 2023
|
7 | $228.5M |
|
Q2 2023 13F
Filed Aug 9, 2023
|
4 | $219.1M |
|
Q1 2023 13F
Filed May 9, 2023
|
5 | $181.0M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
12 | $271.5M |
|
Q3 2022 13F
Filed Nov 10, 2022
|
5 | $80.7M |
|
Q2 2022 13F
Filed Aug 8, 2022
|
5 | $95.5M |
|
Q1 2022 13F
Filed May 11, 2022
|
10 | $213.9M |
|
Q4 2021 13F
Filed Feb 11, 2022
|
15 | $294.2M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
15 | $194.7M |
15 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SPY P STATE STR SPDR S&P 500 ETF T | $104.5M | 30.89% |
| 2 | SLV C ISHARES SILVER TR | $43.3M | 12.8% |
| 3 | TCOM P TRIP COM GROUP LTD | $31.2M | 9.21% |
| 4 | GDX P VANECK ETF TRUST | $24.1M | 7.13% |
| 5 | GDX VANECK ETF TRUST | $9.1M | 2.68% |
| 6 | DXCM 0.375 05/15/28 DEXCOM INC | $7.5M | 2.21% |
| 7 | HAE 2.5 06/01/29 HAEMONETICS CORP MASS | $7.1M | 2.1% |
| 8 | EWZ C ISHARES INC | $6.9M | 2.04% |
| 9 | JD 0.25 06/01/29 JD.COM INC | $6.9M | 2.03% |
| 10 | SMH P VANECK ETF TRUST | $6.6M | 1.94% |
| 11 | IQV C IQVIA HLDGS INC | $6.2M | 1.83% |
| 12 | COPX P GLOBAL X FDS | $6.2M | 1.82% |
| 13 | KWEB C KRANESHARES TRUST | $5.7M | 1.68% |
| 14 | AMT C AMERICAN TOWER CORP | $5.5M | 1.62% |
| 15 | JD P JD.COM INC | $5.5M | 1.61% |
| 16 | TCOM 0.75 06/15/29 TRIP COM GROUP LTD | $5.4M | 1.6% |
| 17 | NLY C ANNALY CAPITAL MANAGEMENT IN | $3.8M | 1.12% |
| 18 | DFTX P DEFINIUM THERAPEUTICS INC | $3.8M | 1.11% |
| 19 | MMYT 0 07/01/30 MAKEMYTRIP LIMITED MAURITIUS | $3.6M | 1.08% |
| 20 | BABA C ALIBABA GROUP HLDG LTD | $3.0M | 0.88% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.